cisapride has been researched along with Esophageal Dysmotility in 11 studies
Cisapride: A substituted benzamide used for its prokinetic properties. It is used in the management of gastroesophageal reflux disease, functional dyspepsia, and other disorders associated with impaired gastrointestinal motility. (Martindale The Extra Pharmacopoeia, 31st ed)
cisapride : The amide resulting from formal condensation of 4-amino-5-chloro-2-methoxybenzoic acid with cis-1-[3-(4-fluorophenoxy)propyl]-3-methoxypiperidin-4-amine. It has been used (as its monohydrate or as its tartrate) for the treatment of gastro-oesophageal reflux disease and for non-ulcer dyspepsia, but its propensity to cause cardiac arrhythmias resulted in its complete withdrawal from many countries, including the U.K., and restrictions on its use elsewhere.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The aim of the study is to compare the clinical efficacy of levosulpiride and cisapride in patients with dysmotility-like functional dyspepsia." | 9.11 | Levosulpiride and cisapride in the treatment of dysmotility-like functional dyspepsia: a randomized, double-masked trial. ( Balboa, A; Jiménez, I; Mearin, F; Patón, C; Pérez-Mota, A; Rodrigo, L; Sebastián, JJ, 2004) |
| " The aim of the study is to compare the clinical efficacy of levosulpiride and cisapride in patients with dysmotility-like functional dyspepsia." | 5.11 | Levosulpiride and cisapride in the treatment of dysmotility-like functional dyspepsia: a randomized, double-masked trial. ( Balboa, A; Jiménez, I; Mearin, F; Patón, C; Pérez-Mota, A; Rodrigo, L; Sebastián, JJ, 2004) |
| "In most patients with progressive systemic sclerosis (PSS) the oesophagus is affected." | 2.70 | Effects of cisapride on oesophageal transit of solids in patients with progressive systemic sclerosis. ( Chen, DY; Chen, YH; Hsieh, TY; La, JL; Lin, WY; Wang, SJ, 2002) |
| "Long-standing gastroesophageal reflux disease (GERD) is frequently associated with impaired esophageal body motility." | 2.69 | [Prokinetic medication after surgical therapy of reflux patients with disorders of esophageal peristalsis: a randomized clinical study]. ( Gadenstätter, M; Klocker, J; Weiss, H; Wetscher, GJ, 2000) |
| "placebo in 12 patients with progressive systemic sclerosis and proven esophageal dysfunction as well as in 10 healthy volunteers in a double-blind, prospective trial." | 2.67 | [Effect of cisapride on esophageal motility in healthy probands and patients with progressive systemic scleroderma]. ( Caspary, WF; Wehrmann, T, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 7 (63.64) | 18.2507 |
| 2000's | 4 (36.36) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mearin, F | 1 |
| Rodrigo, L | 1 |
| Pérez-Mota, A | 1 |
| Balboa, A | 1 |
| Jiménez, I | 1 |
| Sebastián, JJ | 1 |
| Patón, C | 1 |
| Carella, G | 1 |
| Marra, L | 1 |
| Cucchiara, S | 1 |
| Leelamanit, V | 1 |
| Geater, A | 1 |
| Ovartlarnporn, T | 1 |
| Snape, WJ | 1 |
| Song, CW | 1 |
| UM, SH | 1 |
| Kim, CD | 1 |
| Ryu, HS | 1 |
| Hyun, JH | 1 |
| Choe, JG | 1 |
| Gadenstätter, M | 1 |
| Klocker, J | 1 |
| Weiss, H | 1 |
| Wetscher, GJ | 1 |
| Chhina, S | 1 |
| Peverini, RL | 1 |
| Deming, DD | 1 |
| Hopper, AO | 1 |
| Hashmi, A | 1 |
| Vyhmeister, NR | 1 |
| Wang, SJ | 1 |
| La, JL | 1 |
| Chen, DY | 1 |
| Chen, YH | 1 |
| Hsieh, TY | 1 |
| Lin, WY | 1 |
| Wehrmann, T | 1 |
| Caspary, WF | 1 |
| Allen, ML | 1 |
| McIntosh, DL | 1 |
| Robinson, MG | 1 |
1 review available for cisapride and Esophageal Dysmotility
| Article | Year |
|---|---|
Cisapride therapy for gastrointestinal disease.
Topics: Adult; Animals; Child; Cisapride; Constipation; Esophageal Motility Disorders; Gastrointestinal Dise | 1996 |
5 trials available for cisapride and Esophageal Dysmotility
| Article | Year |
|---|---|
Levosulpiride and cisapride in the treatment of dysmotility-like functional dyspepsia: a randomized, double-masked trial.
Topics: Administration, Oral; Adolescent; Adult; Aged; Cisapride; Dose-Response Relationship, Drug; Double-B | 2004 |
Double-blind placebo-controlled study of cisapride in patients with nonspecific esophageal motility disorder accompanied by delayed esophageal transit.
Topics: Adult; Cisapride; Double-Blind Method; Esophageal Motility Disorders; Esophagus; Female; Gastrointes | 1997 |
[Prokinetic medication after surgical therapy of reflux patients with disorders of esophageal peristalsis: a randomized clinical study].
Topics: Adult; Aged; Cisapride; Esophageal Motility Disorders; Female; Follow-Up Studies; Fundoplication; Ga | 2000 |
Effects of cisapride on oesophageal transit of solids in patients with progressive systemic sclerosis.
Topics: Administration, Oral; Adult; Aged; Cisapride; Cross-Over Studies; Double-Blind Method; Esophageal Mo | 2002 |
[Effect of cisapride on esophageal motility in healthy probands and patients with progressive systemic scleroderma].
Topics: Adult; Cisapride; Double-Blind Method; Esophageal Motility Disorders; Esophagus; Female; Humans; Mal | 1990 |
5 other studies available for cisapride and Esophageal Dysmotility
| Article | Year |
|---|---|
[Prokinetic drugs in digestive disorders].
Topics: Antineoplastic Agents; Cisapride; Domperidone; Esophageal Motility Disorders; Gastroesophageal Reflu | 1993 |
Cisapride in the treatment of globus hystericus.
Topics: Adult; Cisapride; Conversion Disorder; Esophageal Motility Disorders; Esophagogastric Junction; Esop | 1997 |
Managing the patient with atypical chest pain.
Topics: Adrenergic Uptake Inhibitors; Algorithms; Amitriptyline; Anti-Ulcer Agents; Atropine; Chest Pain; Ci | 1997 |
QTc interval in infants receiving cisapride.
Topics: Analysis of Variance; Cisapride; Cohort Studies; Dose-Response Relationship, Drug; Drug Administrati | 2002 |
Healing or amelioration of esophagitis does not result in increased lower esophageal sphincter or esophageal contractile pressure.
Topics: Adult; Aged; Cisapride; Esophageal Motility Disorders; Esophagitis; Esophagogastric Junction; Esopha | 1990 |